Liver cirrhosis is independently associated with increased in-hospital mortality in patients undergoing left atrial appendage occlusion device implantation.

[1]  P. Noseworthy,et al.  Utilization and procedural adverse outcomes associated with Watchman device implantation. , 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  K. Gupta,et al.  Outcomes of MitraClip placement in patients with liver cirrhosis. , 2020, Cardiovascular revascularization medicine : including molecular interventions.

[3]  Outcomes and Effects of Hepatic Cirrhosis in Patients Who Underwent Transcatheter Aortic Valve Implantation. , 2018, The American journal of cardiology.

[4]  Saibal Kar,et al.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.

[5]  K. Reddy,et al.  Coagulation disorders and hemostasis in liver disease: Pathophysiology and critical assessment of current management , 2006, Hepatology.